ELICIO THERAPEUTICS INC (ELTX) Stock Balance Sheet
NASDAQ:ELTX - Nasdaq - US28657F1030 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 18.35M | 17.62M | 12.89M | 50.49M | 88.76M | |||
| Receivables | N/A | N/A | 173.00K | 0.00 | 810.00K | |||
| Other Current Assets | 2.58M | 3.08M | 3.28M | 950.00K | 1.69M | |||
| Total Current Assets | 20.93M | 20.69M | 16.35M | 51.43M | 91.25M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.91M | 6.19M | 7.28M | 430.00K | 4.44M | |||
| Investments And Advances | N/A | N/A | N/A | 870.00K | 720.00K | |||
| Other Non-Current Assets | 1.30M | 1.30M | 3.52M | 60.00K | 110.00K | |||
| Total Non-Current Assets | 7.21M | 7.49M | 10.80M | 1.36M | 5.26M | |||
| TOTAL ASSETS | 28.14M | 28.18M | 27.15M | 52.79M | 96.51M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 70.00K | 60.00K | |||
| Accrued Expenses | 6.70M | 9.32M | 4.67M | 1.99M | 4.11M | |||
| Accounts Payable | 4.04M | 1.04M | 4.37M | 2.72M | 4.71M | |||
| Other Current Liabilities | 680.00K | 1.17M | 730.00K | 1.59M | 2.42M | |||
| Total Current Liabilities | 11.41M | 11.52M | 9.77M | 6.37M | 11.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 20.03M | 0.00 | 170.00K | 240.00K | |||
| Other Non-Current Liabilities | 7.83M | 7.93M | 6.01M | 2.48M | 3.48M | |||
| Total Non-Current Liabilities | 7.83M | 27.97M | 6.01M | 2.65M | 3.71M | |||
| TOTAL LIABILITIES | 19.24M | 39.49M | 15.77M | 9.02M | 15.01M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -205.31M | -194.10M | -142.20M | -253.94M | -215.14M | |||
| Additional Paid In Capital | 214.35M | 183.00M | 153.83M | 297.33M | 296.45M | |||
| Common Shares | 160.00K | 110.00K | 96.00K | 300.00K | 300.00K | |||
| Treasury Stock | -150.00K | -150.00K | -150.00K | N/A | 0.00 | |||
| Other Shareholders' Equity | -144.00K | -175.00K | -197.00K | 90.00K | -100.00K | |||
| Shares Outstanding | 15.97M | 11.03M | 9.60M | 3.01M | 3.00M | |||
| Tangible Book Value per Share | 0.56 | -1.03 | 1.18 | 14.54 | 27.17 | |||
| Total Shareholders' Equity | 8.90M | -11.31M | 11.37M | 43.77M | 81.51M | |||
| TOTAL LIABILITIES AND EQUITY | 28.14M | 28.18M | 27.15M | 52.79M | 96.51M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -1.77 | N/A | 0.00 | 0.00 | |||
| Current Ratio | 1.83 | 1.80 | 1.67 | 8.07 | 8.08 | |||
| Return On Assets (ROA) | -182.21% | -184.54% | -129.65% | -73.52% | -56.54% | |||
| Return On Equity (ROE) | -575.93% | N/A | -309.46% | -88.67% | -66.95% | |||
All data in USD , ROIC based on taxRate of 0.21